Antibodies under a microscope

Database

Filter by:

Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity

You are searching for:

  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search

  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search

  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

2621-2630 of 4090 results

Catalogue Number:

PX-TA1349

Category:

G

Proteo Genix logo

Diridavumab Biosimilar – Anti-hemagglutinin HA2 mAb – Research Grade

Target: hemagglutinin HA2
Target Alias Name: Diridavumab/CR-6261/CR6261/hemagglutinin HA2/anti-hemagglutinin HA2
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-lambda
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1574

Category:

G

Proteo Genix logo

Disitamab Biosimilar – Anti-ERBB2/ EGFR2/ CD340 mAb – Research Grade

Target: ERBB2/ EGFR2/ CD340
Target Alias Name: Disitamab /RC48-0/ERBB2/ EGFR2/ CD340/anti-ERBB2/ EGFR2/ CD340
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1657

Category:

G

Proteo Genix logo

Divozilimab Biosimilar – Anti-MS4A1 mAb – Research Grade

Target: MS4A1
Target Alias Name: Divozilimab/DIVOZILIMAB [INN]/IMMUNOGLOBULIN G1/ ANTI-(HUMAN CD20 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL BCD-132 .GAMMA.1-CHAIN)/ DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL BCD-132 .KAPPA.-CHAIN/ DIMER/MS4A1/anti-MS4A1
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1/Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PTX18555-100

Category:

G

Proteo Genix logo

DNA Monoclonal Antibody 33.F12

Target: Isotype Control
Species Reactivity: Other
Type: Primary Recombinant
Isotype/Mimetic: IgG2a/ kappa
Host Species: Mouse
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PTX18556-100

Category:

G

Proteo Genix logo

DNA Monoclonal Antibody 412.67.F1.3

Target: Isotype Control
Species Reactivity: Other
Type: Primary Recombinant
Isotype/Mimetic: IgG2a/ kappa
Host Species: Mouse
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1658

Category:

G

Proteo Genix logo

Docaravimab Biosimilar – Anti-Rabies Virus Strain ERA GP Ectodomain Epitope G-III mAb – Research Grade

Target: Rabies Virus Strain ERA GP Ectodomain Epitope G-III
Target Alias Name: Docaravimab/DOCARAVIMAB [INN]/DOCARAVIMAB [WHO-DD]/IMMUNOGLOBULIN G2/ ANTI-(RABIES VIRUS STRAIN EVELYN-ROCKITNIKI-ABELSETH GLYCOPROTEIN ECTODOMAIN EPITOPE G-III) (MUS MUSCULUS MONOCLONAL .GAMMA.2-CHAIN)/ DISULFIDE WITH MUS MUSCULUS MONOCLONAL .KAPPA.-CHAIN/ DIMER IMMUNOGLOBULIN G2B/ ANTI-(RABIES VIRUS STRAIN EVELYN-ROCKITNIKI-ABELSETH GLYCOPROTEIN ECTODOMAIN EPITOPE G-III) (MUS MUSCULUS MONOCLONAL 62-71-3 .GAMMA.2B-CHAIN)/ DISULFIDE WITH MUS MUSCULUS MONOCLONAL 62-71-3 .KAPPA.-CHAIN/ DIMER IMMUNOGLOBULIN G2B-KAPPA/ ANTI-(RABIES VIRUS STRAINERA (EVELYN-ROCKITNIKI-ABELSETH) GLYCOPROTEIN ECTODOMAIN EPITOPE G-III)/ MUS MUSCULUS MONOCLONAL ANTIBODY/Rabies Virus Strain ERA GP Ectodomain Epitope G-III/anti-Rabies Virus Strain ERA GP Ectodomain Epitope G-III
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG2b/Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1426

Category:

G

Proteo Genix logo

Domagrozumab Biosimilar – Anti-MSTN / GDF8 mAb – Research Grade

Target: MSTN / GDF8
Target Alias Name: Domagrozumab/PF-06252616/MSTN / GDF8/anti-MSTN / GDF8
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1659

Category:

G

Proteo Genix logo

Domvanalimab Biosimilar – Anti-TIGIT mAb – Research Grade

Target: TIGIT
Target Alias Name: Domvanalimab/DOMVANALIMAB/ IMMUNOGLOBULIN G1 (236-ALANINE/237-ALANINE/DE-C-TERMINAL-LYSINE)/ ANTI-(HUMAN RECEPTOR TIGIT)(HUMAN-MUS MUSCULUS MONOCLONAL AB154 .GAMMA.1-CHAIN)/ DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL AB154 .KAPPA.-CHAIN/ DIMER/TIGIT/anti-TIGIT
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1/Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1549

Category:

G

Proteo Genix logo

Donanemab Biosimilar – Anti-APP mAb – Research Grade

Target: APP
Target Alias Name: Donanemab /LY3002813/APP/anti-APP
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA2114

Category:

G

Proteo Genix logo

Donzakimig Biosimilar – Anti-Interleukin-22/ Albumin mAb – Research Grade

Target: Interleukin-22/ Albumin
Species Reactivity: Human
Application: ELISA
Type: Primary Recombinant
Isotype/Mimetic: IgG1(VH-CH1-h)-scFv_L-kappa-scFv
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo